Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Nadir Mahmood returning to Nkarta

Plus: Perry Sternberg named CEO of Sydnexis, and updates from SFA, Alkeus and Optibrium

July 16, 2024 11:53 PM UTC

Nadir Mahmood will return to Nkarta Inc. (NASDAQ:NKTX) this month as president. Mahmood previously joined Nkarta in 2018 as SVP, corporate development, becoming chief financial and business officer in 2020 before leaving to lead Rezo Therapeutics Inc. as CEO in 2023. Nkarta added that it broadened the role of CMO David Shook to include head of R&D. The company is developing CAR NK cells to treat cancer and autoimmune diseases. 

Perry Sternberg became CEO and a board member of  Sydnexis Inc., which is developing therapies for pediatric myopia. Sternberg was president and CEO of Corium Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article